In contrast, tumor expression of SIGLEC8 was significantly higher at early pathological stages compared to stage IV (Fig. 4D); combining formerly type 1 and 2 pRCC showed similar results (Supplementary Fig. 3). This evidence concerns the gene SIGLEC8 and neoplasm.